KYMR Competitors & Alternatives
Compare Kymera Therapeutics Inc with similar stocks in the same industry
Biotechnology
KYMR
Main Stock$128.64
Tradestie Score
37
Market Cap
$3.91B
Revenue Growth
4.7%
Analyst Upside
+12.9%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$261.63
|
$12.36B | 19.7 | 36 | Compare |
|
EXEL
Exelixis Inc
|
$70.11
|
$11.09B | 21.1 | 27 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$40.58
|
$10.76B | - | 31 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$240.48
|
$10.74B | - | 39 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$57.02
|
$10.53B | - | 53 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$27.72
|
$10.49B | - | 45 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$79.48
|
$10.22B | - | 30 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$427.71
|
$10.01B | - | 58 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.84
|
$9.33B | 66.8 | 50 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$74.37
|
$8.88B | 56.4 | 56 | Compare |
More KYMR Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
217 stocks in this industry